{"name":"Santen Pharmaceutical (Taiwan) Co., LTD","slug":"santen-pharmaceutical-taiwan-co-ltd","ticker":"","exchange":"","domain":"","description":"Santen Pharmaceutical Co., Ltd. , is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNeGtvZUphZEVOWlBPNzJIeVBTSWRHOWpsWW9XOWhBOXF1X1VTYlFxc0Q2U2VVNl9YbC1GS0p2R3R0RDYtdk83bUdkQ2tUV1MzSDhpcTcyVzd2TzIyWUUwOGx5TXhoTGxtZ09MYkx2NWxxc2c4cjJsR19nOVFhZG1Xd3haMTVLbTNsTzRENnhta2RrRXNjLVVqLVhXWVU5V2tFOThwT0gyTmpiVEtPYTF0QWVJaDh5bEJWRk1pVEp1LWJmMlVpcWYxejY0TzRnSGhrVDJpY2NHenlQNjNKUk9zcjdfamliNjZaZnQtaWdIcXoxR0VZLWNKdzZHNW10d0RDTjREbm1tR1hQY3hLbDY3NXRRSU1qTHhhdzhJcnVxLTIyQXNiem1jQU5qdVZyYzQ?oc=5","date":"2026-03-26","type":"pipeline","source":"The Norfolk Daily News","summary":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities - The Norfolk Daily News","headline":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNRXI0UWlhdWF0WUdrVFhTRTVod1NCNkc0V2pDLUZKbm5zUGFGckFJeWlhTDJxVVhsbVE2ZV9teVpiQUpFb2pYV09ZUEZmVFZHdUJTT0VEQXZmVV9INzJoeG9wbzdLT0RvR1QxeUtreEgwYVh6ZzNLeGhqTFNxV3FJOWtZUFJKQkhYeHowS3gxbXJtQ3ZpV1pYaTBrR21ZOVc3Z3h4Q09CT0p4OVVEc2wyZDdRa3hVRm1aNnVSekQ5VTRSQQ?oc=5","date":"2026-03-15","type":"pipeline","source":"AD HOC NEWS","summary":"Santen Pharmaceutical stock (ISIN: JP3512800005): Ophthalmology specialist navigates pricing pressur - AD HOC NEWS","headline":"Santen Pharmaceutical stock (ISIN: JP3512800005): Ophthalmology specialist navigates pricing pressur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPOUVfdGdCVTV4Y1p6M0lhMGFXalp2Y0ZuT0JqSlhtdjkwQWxsdW4yRTNBQnU3bnRnZ1lwNXJLX1R4VFVNWXl1cHdDTndkUGpkOFMyczkta0dqR2FJU2JWNjFIemYzSklmMzJGLVV5OFlIcWV4NXpOVDhBV004Y3V0QnBVRGdmS2Mxc1V1VWhlN3A0eUxWSWRRVG11QmxOcDl5UEJBTl8yY2JXc24tSFdjRGdFTUpCQUdjbGM4NkVwXy1md3NsUTZtalF5bF9id0o3QXoxNldlU00xNXdKRUMxX2tvRXdmUEFtdTNQME9hU25qTXRxeW1SN1V2MnRlejJETGU3UlUwaVdPeWVYVXVScw?oc=5","date":"2026-01-12","type":"regulatory","source":"PR Newswire UK","summary":"Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNd1gxZ0tUU0dxMkN2bjRNQVptQXBJODBXTEpsRklRMFc5TkVCN0lOUGM3SUh3eEFTakUwZGRJbW1vM2V2aEFoMGFXZFc1b181MWJoY054ckx3WGR6RzhnakhPTkVxeUF1bkZfXzd3YW53NFI5T0xyS2xlcFBvT1FJNXN4UVY4NXVLU1dnRHdGVFNocnVYaW92RkQtVmZjZWxra20yLXl3MFFFZnpWbG5LeDI0TWxNSWQyUjZUTUxqN0FOSER2bF9tQl81b19McE5nSGQ4VzRvc0pNbmttekxGVThZVjhSaEEwMHkyeHliRVZhU19IYXF1clFRdFZja2VfS0FwbHNqUWoycUU4YXBsZjVONmxhRlhhVVE?oc=5","date":"2025-08-18","type":"pipeline","source":"PR Newswire","summary":"RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries - PR Newswire","headline":"RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9wQ0hlMjVZYlZtSGxNM3o4U1BYN0VTbFMzYm5UVFJnZDhMblVNYnZsZzRsUUtNdl9BellRYWdDejhKWXE4MzJQVmR2clV0VDNVdUFQamZVOVVXZmlhT21Dak9QNmt1UWNmSXhNcFY4dHE?oc=5","date":"2025-06-23","type":"pipeline","source":"rakuten-med.com","summary":"Rakuten Medical Strengthens Executive Team with Appointment of CFO Andrew Liu - rakuten-med.com","headline":"Rakuten Medical Strengthens Executive Team with Appointment of CFO Andrew Liu - rakuten","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQQVpld2hXNUhFTEptcm1MZVJFellnal9IWVo5Mjd1UkVRb0tVY0pxV2hvSDd2Y2ZGZ0xXNU9zTDY4eGFjNEI5R1JuTmdmUW9WYldWM2pMekdKVE9jNXRmOUx6a25XUlNLQ241dnhGVnZTLWFscG5GbmRUbzJ0RkhWMEN0NzhfSk92MWl0OU9QWDlCUVJ0VXduWFl2NndMRTFNNkU1bU5KdU56QTVfbktBNU0zYURhblZCTEVZZDhiSGxFWEhtUlRyY1F3bTdrTC0ybTZmU05lWTd2clNvQThmYUtpRjhGZHF0bWl6cXVwYlNyWFU?oc=5","date":"2024-04-09","type":"regulatory","source":"PR Newswire","summary":"Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54% in the US by 2034 | DelveInsight - PR Newswire","headline":"Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54% in the US by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9rejRTVE9jcXdRd2VUeUpNNkVSUkFxbUUtYVlvc1ZwdFVpX0tvMGVRS0FWb2hhdXRDT25BTmJfOVlja1VLVHBmU0NJdmVkSjBFeFgtc3hhWDNTeWlZdGJvTXQ4dkVPclNOc0htdA?oc=5","date":"2023-08-01","type":"regulatory","source":"Straits Research","summary":"Glaucoma Treatment Market Size, Demand, Top Share, Forecast to 2033 - Straits Research","headline":"Glaucoma Treatment Market Size, Demand, Top Share, Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5scng2VzdjcVd3dXlwTklnek9scWMtRC1FZzVVc2poTE1TT2tRSDNXaWFCVTlkbXlsSzg5VVhYdUloVGNKSE95OVFkSjFGYkN2VnNBbmRlWDcyUXhTcXlYemJ0Z3h5ZzN5NExPRnZIZU1XWTN1aVQw?oc=5","date":"2023-06-02","type":"regulatory","source":"Straits Research","summary":"Global Dry Eye Syndrome Treatment Market Size, Top Share, Demand, Forecast to 2033 - Straits Research","headline":"Global Dry Eye Syndrome Treatment Market Size, Top Share, Demand, Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE15c3o0bUFvUUlBSWtVT3BhdG1rU3BYMkFKbVViQnhFTEpOdUJCdFoxVDV3bWVwbjJPanlKekExNDdMbjQtclJFdTBwd0pVR2tKeXZaWlhpVTJTTEtZbmpxRlpKdV9mdW5KZ2c?oc=5","date":"2023-01-06","type":"pipeline","source":"Straits Research","summary":"Ophthalmic Drugs Market Size, Share & Trends | Industry Report, 2034 - Straits Research","headline":"Ophthalmic Drugs Market Size, Share & Trends | Industry Report, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE41MnZ3OFhiUkZwOU40U2N5SFVoT0hMa0NjTjdVazJsa3FyTkRPZldTa2MyRWthUXVwMUJTdVFxbEhpMkpHd0szQnFuSWp6SDUwdnFtaE8tZjg3MjdSUUlQYmc5MHBDMTFzNko4WlBvRjhpbFRrVTlMTm9Zbndidw?oc=5","date":"2020-05-20","type":"pipeline","source":"Fact.MR","summary":"Ocular Drug Delivery Technology Market Statistics - 2034 - Fact.MR","headline":"Ocular Drug Delivery Technology Market Statistics - 2034","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}